Real-time enrollment status for this myeloproliferative neoplasms clinical trial
Current Status
Recruiting
Checked: November 10, 2026 at 1:56 AM UTC
| NCT Number | NCT06661915 |
| Recruiting Status | Recruiting |
| Condition | Myeloproliferative Neoplasms |
| Phase | PHASE2 |
| Target Enrollment | 78 participants |
| Active Locations | 32 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 27, 2026 (2 weeks ago) |
As of November 10, 2026: Clinical trial NCT06661915 is currently recruiting participants. This phase2 study for myeloproliferative neoplasms is actively seeking new participants at 32 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06661915 is actively recruiting participants as of November 10, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06661915 was last updated 2 weeks ago (October 27, 2026). HelloStudys verifies this status automatically.